ANU VERGIS: Open Payments
NPI 1265075543 · FEASTERVILLE TREVOSE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 21 payments from 11 companies in 2025. Trend: 2023 $155 · 2024 $324 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $117 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Exact Sciences Corporation | 3 | $54 |
| Optinose US, Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Amgen Inc. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| MILLICENT US INC | 1 | $15 |
Products named: SPRAVATO, AIRSUPRA, Xhance, FARXIGA, SHINGRIX, The Cologuard Plus Collection Kit, REPATHA, OPSUMIT.
Industry payments across PA — which companies pay providers there.
